Match Document Document Title Score
US20180264014 COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS  
Provided are compositions and methods for treating multiple sclerosis (MS). One embodiment of the disclosed method entails orally administering to a MS patient a first amount of aspirin and a...
239
US20090098201 Composition and Method for Treatment and Prevention of Atherosclerosis  
This invention relates to an oral composition for treatment or prevention of atherosclerosis comprising a low-dose aspirin and a low-dose of statin wherein the aspirin and statin are in a...
236
4579843 Analgesic and anti-inflammatory compositions  
Analgesic and anti-inflammatory compositions are provided which comprise a therapeutically effective amount of a first agent selected from the group consisting of D-phenylalanine, DL-phenylalnine,...
236
4294819 Alkaline analgesic capsule  
There is disclosed a capsule containing aspirin and alternatively other active analgesic materials in combination with an alkaline material. The composition is made stable by providing the...
229
5989578 Associations of active principles containing clopidogrel and an antithrombotic agent  
The invention relates to a pharmaceutical composition containing an association of active principles, wherein the active principles are clopidogrel and aspirin, each constituent being present in a...
228
9226891 Anti-flush compositions  
Disclosed are pharmaceutical compositions having a portion of aspirin for intraoral release and another aspirin for gastrointestinal release. The compositions can further include niacin. Methods...
227
7081347 Method for predicting cardiovascular events  
A method for assessing aspirin resistance and relative risk of a cardiovascular event in a patient taking aspirin is provided. The concentration of 11-dehydro-thromboxane B2 in a urine sample is...
224
8105790 Methods and kits for detection of thromboxane A2 metabolites  
Methods, compositions and kits are provided for measuring aspirin's anti-thrombotic effectiveness on a subject. Included are a novel assay for quickly and specifically measuring TxA2 metabolite...
222
4534974 Pharmaceutical compositions with codeine  
Compositions for the relief of pain, muscle spasm and limited mobility associated with acute painful muscoloskeletal conditions are disclosed. Such compositions comprise in combination, a...
222
4534973 Pharmaceutical compositions  
Compositions for the relief of pain, muscle spasm and limited mobility associated with acute painful muscoloskeletal conditions are disclosed. Such compositions comprise in combination, a...
222
4012508 Topical composition and method  
An ointment for topical use comprising a small amount of a cortical steroid intimately mixed with aspirin in a suitable carrier such as petroleum jelly wherein about 45 to 125 parts of the steroid...
220
7767646 Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds  
Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be...
219
6524630 Use of cocoa procyanidins combined with acelylsalicyclic acid as an anti-platelet therapy  
The invention relates to the use of cocoa procyanidins in combination with an aspirin as an anti-platelet therapy and compositions comprising cocoa procyanidins and aspirin (acetylsalicyclic acid).
218
5055460 Method for weight loss  
A method for producing or maintaining weight loss by administering to a human a composition containing an effective amount of each of caffine, aspirin and ephedrine. The pharmaceutical composition...
215
US20090023692 COMPOSITIONS FOR INHIBITING AND PREVENTING VASCULAR OCCLUSION CONTAINING NUTRITIONAL SUPPLEMENTS  
Compositions for inhibiting vascular occlusion in humans comprising aspirin for inhibiting vascular occlusion which further contain nutritional supplements are disclosed. The compositions are...
214
US20170087167 MODIFICATION OF DRUGS FOR INCORPORATION INTO NANOPARTICLES  
Aspirin is chemically modified to generate a prodrug that releases aspirin in cellular milieu. The prodrug has a lipophilic tail that may enhance uptake efficiency in nanoparticles. Nanoparticles...
214
4867984 Drug in bead form and process for preparing same  
A bead of a drug such as aspirin or acetaminophen formed from a small spheriodal seed particle of the drug or of an inert material coated with an adhesive and layers of drug particles likewise...
213
9433645 Method and composition for preventing stem cell disruption and aggregation  
There is provided a method for preventing disruption and aggregation of stem cells. In addition, there is provided a stem cell composition for intravascular administration, in which stem cells are...
213
US20160143922 ANTI-FLUSH COMPOSITIONS  
Disclosed are pharmaceutical compositions having a portion of aspirin for intraoral release and another aspirin for gastrointestinal release. The compositions can further include niacin. Methods...
212
US20120178724 Compositions for Reducing the Incidence of Drug Induced Arrhythmia  
In accordance with the present invention, novel methods and formulations are provided for treating and preventing the incidence of drug-induced pro-arrhythmia, including torsades de pointes. The...
211
US20100310540 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIA ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS  
Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be...
211
US20070059356 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen  
A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde,...
211
US20160159779 CO-CRYSTAL OF THE PAR-1 RECEPTOR ANTAGONISTS VORAPAXAR AND ASPRIN  
This invention relates to a co-crystal of vorapaxar and aspirin. The inventive co-crystal antagonizes the PAR-1 receptor. This invention also provides for pharmaceutical compositions comprising...
208
US20050026992 Treatment and prevention of cardiovascular events  
A pharmaceutical dosage form for treating or preventing cardiovascular events comprises therapeutic amounts of: a β-adrenergic receptor antagonist, a diuretic, or both; a cholesterol-lowering...
205
5681856 Method of reducing focal ulcerative dermatitis (FUD) in poultry  
Focal Ulcerative Dermatitis in poultry raised for consumption is prevented and treated by a method which includes the step of administering orally an effective level of aspirin over a prolonged...
205
5852047 Pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor  
Salicylates of esterifiable ACE-inhibitors, especially captopril-S-aspirinate, and processes for their preparation are described. Such compounds are useful as analgesics, in the process of...
203
US20050222096 Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds  
Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be...
203
3887700 Analgesic formulations  
Free-flowing readily wettable aspirin particles comprise a core of aspirin substantially encompassed by a layer comprising a water-soluble pharmaceutically acceptable coating material having a...
202
US20100227417 Methods and Kits for Detection of Thromboxane A2 Metabolites  
Methods, compositions and kits are provided for measuring aspirin's anti-thrombotic effectiveness on a subject. Included are a novel assay for quickly and specifically measuring TxA2 metabolite...
202
US20160122991 Toilet Water Splash Inhibiting Device  
A toilet water splash inhibiting device for inhibit splashing of toilet water during evacuation of waste into a toilet. The device includes a mixture of liquid body soap, baking soda, vinegar,...
202
US20170348332 SALICYLATE COMPOUND COMPOSITION  
A liquid composition contains a salicylate compound (e.g. aspirin), glycerin triacetate, saccharin. The salicylate compound is soluble in the composition, which is particularly suitable for oral,...
201
4859658 Compound compositions with improved analgesic antipyretic and anti-inflammatory activity  
Pharmaceutical compositions containing thioacetamol and an amount of a non-steroidal anti-inflammatory drug selected from aspirin, indomethacin, dichlofenac, naproxen, sulindac and fenbufen...
200
US20140322328 DRY POWDER FORMULATIONS AND METHODS OF USE  
The subject technology relates generally to pulmonary delivery of NSAIDs, such as aspirin.
200
4132788 Antiarthritic potentiation  
The anti-inflammatory and antiarthritic properties of 5-aroyl-1-loweralkyl-pyrrole-2-acetic acid derivatives are potentiated by acetaminophen and aspirin.
200
US20080051417 Uses of selective cyclooxygenase-1 inhibitors  
The present invention discloses effect of non-selective COX1 inhibitor such as aspirin, statins, thiazolidinediones or combinations thereof on COX2. Also disclosed herein is a method to avoid the...
198
US20070021395 Compositions for reducing the incidence of drug induced arrhythmia  
In accordance with the present invention, novel methods and formulations are provided for treating and preventing the incidence of drug-induced pro-arrhythmia, including torsades de pointes. The...
198
US20040096521 METHOD AND COMPOSITION FOR TREATING HAIRY HOOF WARTS  
Hairy hoof warts in animals are treated by topically administering an effective amount of a composition of aspirin or other compound or derivative of salicylic acid that preferably contains at...
197
US20100068269 TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS  
A pharmaceutical dosage form for treating or preventing cardiovascular events comprises therapeutic amounts of: a β-adrenergic receptor antagonist, a diuretic, or both; a cholesterol-lowering...
196
US20080113951 TREATMENT OF INFLAMMATORY, CANCER, AND THROMBOSIS DISORDERS  
A pharmaceutical composition and a method of treating inflammation in a mammal. The method administers the therapeutic composition to the mammal. The therapeutic composition includes: a standard...
195
6863898 Method and composition for treating hairy hoof warts  
Hairy hoof warts in animals are treated by topically administering an effective amount of a composition of aspirin or other compound or derivative of salicylic acid that preferably contains at...
195
US20080305508 Methods of screening for compounds that modulate TAFIa activity, compounds, and methods of using the compounds  
Provided are methods of screening compounds for any aspirin-related activity other than TAFI inhibition, and also for non-inhibition of TAFI. Compounds identified by the screening methods can be...
195
US20080006556 Apparatus for carrying heart related medication  
An apparatus for holding one of aspirin, nitroglycerine or other emergency medication for a person who may be at risk for a heart attack. The apparatus comprises a key shaped member having a...
190
8183284 Compositions for reducing the incidence of drug induced arrhythmia  
In accordance with the present invention, novel methods and formulations are provided for treating and preventing the incidence of drug-induced pro-arrhythmia, including torsades de pointes. The...
190
5773453 Methods for administration of antilipemic drugs  
The present invention concerns methods for reducing cutaneous flushing in a patient to whom niacin is administered. According to the present method, two or more doses of a nonsteroidal...
188
US20190105267 DRY POWDER FORMULATIONS AND METHODS OF USE  
The subject technology relates generally to pulmonary delivery of NSAIDs, such as aspirin.
188
US20030143271 Drug mixture with enhanced dissolution rate  
A pharmaceutical composition comprises one or more discrete orally deliverable dosage forms, each comprising a poorly soluble coxib component in an amount effective when administered once daily...
187
4743596 Anti-arthritic preparation  
An anti-arthritic preparation consisting essentially of the anti-inflammatory, nonsteroidal agents aspirin and phenylbutazone, the anti-inflammatory corticosteroid prednisone, and the skeletal...
186
US20030045562 Treatment of inflammatory, cancer, and thrombosis disorders  
This invention provides for the treatment of inflammatory, cancer and thrombotic disorders through the administration, in combination, of a COX2 inhibitor, low dose aspirin, and antioxidant...
186
US20160022575 SYSTEM FOR ADMINISTRATION OF CARDIAC PROTECTIVE THERAPY  
An dosage member, comprising a planar member comprising a saliva-dissolvable member, a therapeutic agent carried in said planar member, wherein the saliva-dissolvable member is printed or...
183
US20070053892 Methods and kits for co-administration of nutritional supplements  
The present invention relates to methods of co-administration of various vitamin, mineral and aspirin compositions, and in a specific embodiment, comprise co-administering one composition...
182


Search
« search again